Synairgen (SNG) News Today → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free SNG Stock Alerts GBX 6.24 +0.04 (+0.65%) (As of 05/1/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSynairgen (LON:SNG) Share Price Crosses Above 50 Day Moving Average of $5.45americanbankingnews.com - April 24 at 4:28 AMSonagi SGPS SA SNGmorningstar.com - April 4 at 11:28 PMSynairgen plc (SYGGF) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - February 8 at 7:01 PMSynairgen plc (SNG.L)uk.finance.yahoo.com - February 7 at 12:58 PMCompanies Like Synairgen (LON:SNG) Are In A Position To Invest In Growthfinance.yahoo.com - January 22 at 2:18 PMSynairgen PLC SYGGFmorningstar.com - December 23 at 8:54 AMSynairgen PLC OMYmorningstar.com - December 16 at 5:47 PMSynairgen PLC SNGmorningstar.com - December 16 at 5:47 PMSNGN Romgaz SA SNGmorningstar.com - November 22 at 11:31 PMSynairgen Finance Chief John Ward Steps Down; Colliver Named as Replacementmarketwatch.com - October 11 at 8:31 AMSynairgen appoints new CFO as incumbent bows out after nearly 20 yearsproactiveinvestors.com - October 11 at 8:31 AMSynairgen takes targeted approach with lead assetproactiveinvestors.com - September 21 at 9:25 AMSynairgen looking beyond COVID in fight against respiratory illnessfinance.yahoo.com - September 21 at 9:25 AMWe Think Synairgen (LON:SNG) Needs To Drive Business Growth Carefullyfinance.yahoo.com - June 13 at 6:47 PMSNG.L - Synairgen plcfinance.yahoo.com - June 9 at 10:47 PMCompanies Like Synairgen (LON:SNG) Could Be Quite Riskyfinance.yahoo.com - January 4 at 8:13 AMFTSE 100 jumps 140 points as L&G statement reassures - Proactive Investors USAproactiveinvestors.com - October 4 at 12:29 PMSynairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19finance.yahoo.com - October 4 at 12:29 PMSynairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19 - Business Wirebusinesswire.com - October 4 at 7:29 AMSynairgen Shares Drop Amid Phase 3 Study Issues; Pretax Loss Narrows - MarketWatchmarketwatch.com - September 30 at 4:42 AMEARNINGS SUMMARY: Angle revenue up; Synairgen, Bango loss widens | Financial News - London South Eastlse.co.uk - September 29 at 6:41 PMTesla appoints Airbnb co-founder Joe Gebbia to board - Proactive Investors USAproactiveinvestors.com - September 29 at 8:39 AMSynairgen to Present 60 and 90-day Long COVID Data From Phase 3 SPRINTER Study in Hospitalised COVID-19 Patients at IDWeek 2022finance.yahoo.com - September 20 at 3:42 PMSynairgen's SNG001 Reduces Long COVID-19 Symptoms In Follow-up Visits After Late-stage Trial - Marketscreener.commarketscreener.com - September 20 at 7:52 AMSynairgen to present data showing drug lowers risk of long Covid symptoms - Proactive Investors USAproactiveinvestors.com - September 20 at 7:52 AMIN BRIEF: Synairgen shares rise as positive data found for COPD | Financial News - London South Eastlse.co.uk - September 7 at 10:35 AMSynairgen announces positive findings from analysis of lung samples from the SG015 trial of SNG001 in virally infected COPD patientsfinance.yahoo.com - September 7 at 10:35 AMSynairgen Gets Positive Data From Trial of Respiratory Drug Treatment - MarketWatchmarketwatch.com - September 7 at 4:50 AMSynairgen unveils positive clinical trial data | Financial News - London South Eastlse.co.uk - September 7 at 4:50 AMSynairgen reports positive data from respiratory viral infection drug - Proactive Investors USAproactiveinvestors.com - September 7 at 4:50 AMFTSE 100 opens lower as oil giants push ahead - Proactive Investors USAproactiveinvestors.com - September 5 at 5:32 PMTRADING UPDATES: Bradda wins drilling approval; Oakley invests in vLex - Morningstarmorningstar.co.uk - September 5 at 5:32 PMSynairgen to play key role in respiratory viral infection study - Proactive Investors USAproactiveinvestors.com - September 5 at 4:32 AMThe Synairgen share price crashes again as US study is haltedfool.co.uk - August 5 at 11:49 PMChronic Obstructive Pulmonary Disease Clinical Trial Pipeline Insights | DelveInsight - GlobeNewswireglobenewswire.com - June 29 at 4:39 PMCan Synairgen (LON:SNG) Afford To Invest In Growth?finance.yahoo.com - May 31 at 5:08 AMIN BRIEF: Synairgen shares fall as loss widens on higher costs - Morningstarmorningstar.co.uk - May 27 at 9:15 AMIN BRIEF: Synairgen shares fall as loss widens on higher costs | Financial News - London South Eastlse.co.uk - May 25 at 1:11 PMSynairgen "working in haste" to plan new lung infection trials - Proactive Investors USAproactiveinvestors.com - May 25 at 8:10 AMSynairgen PLC on presenting at the ATS conference in San Franciscoca.proactiveinvestors.com - May 19 at 10:30 PMSynairgen Presents Detailed Analysis of Phase 3 SPRINTER Trial Evaluating SNG001 in Hospitalised COVID-19 Patients at ATS 2022 - Business Wirebusinesswire.com - May 16 at 5:01 PMSynairgen Presents Detailed Analysis of Phase 3 SPRINTER Trial Evaluating SNG001 in Hospitalised COVID-19 Patients at ATS 2022finance.yahoo.com - May 16 at 9:23 AMSynairgen Shares Rise on Positive Analysis of Phase 3 Covid-19 Treatment Trial - MarketWatchmarketwatch.com - May 16 at 4:23 AMWhat's next for the Synairgen (LON: SNG) share price? - The Motley Fool UK - Motley Fool UKfool.co.uk - April 25 at 12:16 PMSynairgen to present further analysis of Phase 3 SPRINTER trial in hospitalised patients with COVID-19 at the ATS 2022 International Conference - Yahoo Financefinance.yahoo.com - April 6 at 5:05 AMSynairgen to present further analysis of Phase 3 SPRINTER trial in hospitalised patients with COVID-19 at the ATS 2022 International Conferencefinance.yahoo.com - April 5 at 9:54 AMSynairgen to present data from phase III Covid trial at leading industry conference - Proactive Investors USAproactiveinvestors.com - April 5 at 4:54 AMAIM WINNERS & LOSERS: Synairgen sinks 18% after US Covid study halted - Morningstarmorningstar.co.uk - March 17 at 5:49 PMAIM WINNERS & LOSERS: dotDigital plunges after profit warning - Morningstarmorningstar.co.uk - March 3 at 7:41 AMAIM WINNERS & LOSERS: Morses Club sinks on profit warning, CEO exit - Morningstarmorningstar.co.uk - February 21 at 1:31 PM Get Synairgen News Delivered to You Automatically Sign up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Bill Clinton Backing Biden Replacement??? (Ad)Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August… Click here now for my urgent election forecast. SNG Media Mentions By Week SNG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNG News Sentiment▼0.670.35▲Average Medical News Sentiment SNG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNG Articles This Week▼00▲SNG Articles Average Week Get Synairgen News Delivered to You Automatically Sign up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ondine Biomedical News Today OptiBiotix Health News Today Oncimmune News Today Oxford BioDynamics News Today BiVictriX Therapeutics News Today ImmuPharma News Today Destiny Pharma News Today Hemogenyx Pharmaceuticals News Today Roquefort Therapeutics News Today C4X Discovery News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SNG) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlace😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersForget Nvidia. This is the future of AIPorter & CompanyBiden out June 13; Kamala won’t replace him?Paradigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synairgen plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
